Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy

Author： Goldstein Robert Stefanato Catherine M Warbey Victoria Harries Mark

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.9, 2012-09, pp. : 1199-1203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A case of T1N0M0 vulvar apocrine gland carcinoma with a positive outcome

By Ota Y. Fukasawa I. Shimizu K. Okajima Y. Inaba N.

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 601-604

Elsevier

Access to resources Recommend Favorite

Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors

Current Cancer Therapy Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 51-61

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen and Progesterone Receptors in the Endometrium of Postmenopausal Breast Cancer Patients Treated with Tamoxifen and Progestogens

By Cohen I. Altaras M.M. Beyth Y. Shapira J. Figer A. Tepper R. Cordoba M. Yigal D. Bernheim J.

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 83-88

Elsevier

Access to resources Recommend Favorite

Retinoid Receptors in Human Breast Carcinoma: Possible Modulators of in Situ Estrogen Metabolism

By Suzuki T.

Breast Cancer Research and Treatment, Vol. 65, Iss. 1, 2001-01 ,pp. : 31-40

Springer Publishing Company

Access to resources Recommend Favorite

Thrombocytosis in Women with Vulvar Carcinoma

By Lavie O. Comerci G. Daras V. Bolger B.S. Lopes A. Monaghan J.M.

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 82-86

Elsevier

Access to resources Recommend Favorite